The name of this superfamily has been modified since the most recent official CATH+ release (v4_2_0). At the point of the last release, this superfamily was named:

"
TolB, C-terminal domain
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 33068: Low-density lipoprotein receptor 2

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 117 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
82 A1Z9D7 (/IPI) A1Z9D7 (/IPI) A2ARV4 (/IPI) A2ARV4 (/IPI) A2ARV4 (/IPI) A2ARV4 (/IPI) A2ARV4 (/IPI) A2ARV4 (/IPI) B5DFC9 (/IPI) E1BGJ0 (/IPI)
(72 more)
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
16 P01130 (/TAS) P35951 (/TAS) P35952 (/TAS) P98155 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS)
(6 more)
Receptor activity GO:0004872
Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
15 A0A0B4KHW9 (/IMP) A0A0B4KI25 (/IMP) A8JRD0 (/IMP) A8JRD1 (/IMP) A8JRD2 (/IMP) E1JIX9 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP)
(5 more)
Wnt-protein binding GO:0017147
Interacting selectively and non-covalently with Wnt-protein, a secreted growth factor involved in signaling.
14 A1Z9D7 (/IPI) A1Z9D7 (/IPI) O75197 (/IPI) O75197 (/IPI) O75197 (/IPI) O75581 (/IPI) O75581 (/IPI) O75581 (/IPI) O88572 (/IPI) O88572 (/IPI)
(4 more)
Receptor tyrosine kinase binding GO:0030971
Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Scaffold protein binding GO:0097110
Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Receptor activity GO:0004872
Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
10 P98158 (/TAS) P98158 (/TAS) P98158 (/TAS) P98158 (/TAS) P98158 (/TAS) P98158 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
8 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA) P01130 (/IDA) P35951 (/IDA) Q9JI18 (/IDA) Q9JI18 (/IDA) Q9JI18 (/IDA)
Alpha-2 macroglobulin receptor activity GO:0016964
Combining with alpha-2 macroglobulin and delivering alpha-2 macroglobulin into the cell via receptor-mediated endocytosis.
8 P98157 (/ISS) P98157 (/ISS) P98157 (/ISS) P98157 (/ISS) Q91ZX7 (/ISS) Q91ZX7 (/ISS) Q91ZX7 (/ISS) Q91ZX7 (/ISS)
Apolipoprotein binding GO:0034185
Interacting selectively and non-covalently with an apolipoprotein, the protein component of a lipoprotein complex.
8 P98165 (/IPI) Q07954 (/IPI) Q07954 (/IPI) Q07954 (/IPI) Q07954 (/IPI) Q9QYP1 (/IPI) Q9QYP1 (/IPI) Q9QYP1 (/IPI)
Lipoprotein particle binding GO:0071813
Interacting selectively and non-covalently with a lipoprotein particle. A lipoprotein particle, also known as a lipoprotein, is a clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids.
8 A0A0B4KGZ9 (/IPI) A0A0B4KH38 (/IPI) A8JRC4 (/IPI) A8JRC7 (/IPI) Q7YTZ6 (/IPI) Q7YU01 (/IPI) Q86B77 (/IPI) Q9VBN2 (/IPI)
Receptor activity GO:0004872
Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
6 A2ARV4 (/ISS) A2ARV4 (/ISS) A2ARV4 (/ISS) A2ARV4 (/ISS) A2ARV4 (/ISS) A2ARV4 (/ISS)
Wnt-protein binding GO:0017147
Interacting selectively and non-covalently with Wnt-protein, a secreted growth factor involved in signaling.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Wnt-protein binding GO:0017147
Interacting selectively and non-covalently with Wnt-protein, a secreted growth factor involved in signaling.
6 O75197 (/TAS) O75197 (/TAS) O75197 (/TAS) O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
Toxin transporter activity GO:0019534
Enables the directed movement of a toxin into, out of or within a cell, or between cells. A toxin is a poisonous compound (typically a protein) that is produced by cells or organisms and that can cause disease when introduced into the body or tissues of an organism.
6 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP) O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
PDZ domain binding GO:0030165
Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.
6 P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI)
Hemoglobin binding GO:0030492
Interacting selectively and non-covalently with hemoglobin, an oxygen carrying, conjugated protein containing four heme groups and globin.
6 P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
Receptor tyrosine kinase binding GO:0030971
Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
6 Q8VI56 (/IPI) Q8VI56 (/IPI) Q8VI56 (/IPI) Q9QYP1 (/IPI) Q9QYP1 (/IPI) Q9QYP1 (/IPI)
Protein complex binding GO:0032403
Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
6 P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI)
Apolipoprotein binding GO:0034185
Interacting selectively and non-covalently with an apolipoprotein, the protein component of a lipoprotein complex.
6 P98155 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q924X6 (/IDA)
Hormone binding GO:0042562
Interacting selectively and non-covalently with any hormone, naturally occurring substances secreted by specialized cells that affect the metabolism or behavior of other cells possessing functional receptors for the hormone.
6 P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI)
Lipoprotein transporter activity GO:0042954
Enables the directed movement of any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids, into, out of or within a cell, or between cells.
6 P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS)
Low-density lipoprotein particle receptor binding GO:0050750
Interacting selectively and non-covalently with a low-density lipoprotein receptor.
6 P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI) P98158 (/IPI)
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
6 P98164 (/IPI) P98164 (/IPI) P98164 (/IPI) P98164 (/IPI) P98164 (/IPI) P98164 (/IPI)
Coreceptor activity involved in Wnt signaling pathway GO:0071936
In cooperation with a primary Wnt receptor, initiating a change in cell activity through the Wnt signaling pathway.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Coreceptor activity involved in canonical Wnt signaling pathway GO:1904928
Any coreceptor activity that is involved in a canonical Wnt signaling pathway.
6 O75197 (/NAS) O75197 (/NAS) O75197 (/NAS) O75581 (/NAS) O75581 (/NAS) O75581 (/NAS)
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
5 G3V928 (/IPI) G3V928 (/IPI) G3V928 (/IPI) G3V928 (/IPI) P01130 (/IPI)
Apolipoprotein binding GO:0034185
Interacting selectively and non-covalently with an apolipoprotein, the protein component of a lipoprotein complex.
5 P98156 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Wnt-activated receptor activity GO:0042813
Combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity.
5 A1Z9D7 (/IDA) A1Z9D7 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA)
RNA binding GO:0003723
Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
4 Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA)
RNA binding GO:0003723
Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
4 Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
4 E9QGD4 (/IMP) P01130 (/IMP) P35951 (/IMP) P35952 (/IMP)
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
4 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) P35951 (/ISO)
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
4 Q91ZX7 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA)
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Alpha-2 macroglobulin receptor activity GO:0016964
Combining with alpha-2 macroglobulin and delivering alpha-2 macroglobulin into the cell via receptor-mediated endocytosis.
4 Q07954 (/IMP) Q07954 (/IMP) Q07954 (/IMP) Q07954 (/IMP)
Alpha-2 macroglobulin receptor activity GO:0016964
Combining with alpha-2 macroglobulin and delivering alpha-2 macroglobulin into the cell via receptor-mediated endocytosis.
4 Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Alpha-2 macroglobulin receptor activity GO:0016964
Combining with alpha-2 macroglobulin and delivering alpha-2 macroglobulin into the cell via receptor-mediated endocytosis.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Apolipoprotein receptor activity GO:0030226
Combining with an apolipoprotein to initiate a change in cell activity.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Very-low-density lipoprotein particle receptor activity GO:0030229
Combining with a very-low-density lipoprotein particle and delivering the very-low-density lipoprotein into the cell via endocytosis.
4 P01130 (/IDA) P35951 (/IDA) P98155 (/IDA) Q14114 (/IDA)
Protein complex binding GO:0032403
Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
4 Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA)
Protein complex binding GO:0032403
Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
4 Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
4 O75581 (/IPI) O75581 (/IPI) O75581 (/IPI) P01130 (/IPI)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
4 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) P35951 (/ISO)
Lipoprotein transporter activity GO:0042954
Enables the directed movement of any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids, into, out of or within a cell, or between cells.
4 Q07954 (/NAS) Q07954 (/NAS) Q07954 (/NAS) Q07954 (/NAS)
Heparan sulfate proteoglycan binding GO:0043395
Interacting selectively and non-covalently with a heparan sulfate proteoglycan, any proteoglycan containing heparan sulfate as the glycosaminoglycan carbohydrate unit.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Lipoprotein particle receptor binding GO:0070325
Interacting selectively and non-covalently with a lipoprotein particle receptor.
4 Q07954 (/IC) Q07954 (/IC) Q07954 (/IC) Q07954 (/IC)
Glycoprotein binding GO:0001948
Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans.
3 P01130 (/IPI) P98155 (/IPI) Q924X6 (/IPI)
Receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
3 O75581 (/IPI) O75581 (/IPI) O75581 (/IPI)
Receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Frizzled binding GO:0005109
Interacting selectively and non-covalently with the frizzled (fz) receptor.
3 O75581 (/IPI) O75581 (/IPI) O75581 (/IPI)
Frizzled binding GO:0005109
Interacting selectively and non-covalently with the frizzled (fz) receptor.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Sterol transporter activity GO:0015248
Enables the directed movement of sterols into, out of or within a cell, or between cells. Sterol are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.
3 Q04833 (/IMP) Q04833 (/IMP) Q04833 (/IMP)
Wnt-protein binding GO:0017147
Interacting selectively and non-covalently with Wnt-protein, a secreted growth factor involved in signaling.
3 O75197 (/ISS) O75197 (/ISS) O75197 (/ISS)
Kinase inhibitor activity GO:0019210
Stops, prevents or reduces the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
3 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Kinase inhibitor activity GO:0019210
Stops, prevents or reduces the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Very-low-density lipoprotein particle receptor activity GO:0030229
Combining with a very-low-density lipoprotein particle and delivering the very-low-density lipoprotein into the cell via endocytosis.
3 P35951 (/ISO) P98156 (/ISO) Q924X6 (/ISO)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
3 Q8VI56 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
3 O75581 (/IPI) O75581 (/IPI) O75581 (/IPI)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Wnt-activated receptor activity GO:0042813
Combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity.
3 O75197 (/ISS) O75197 (/ISS) O75197 (/ISS)
Low-density lipoprotein particle receptor binding GO:0050750
Interacting selectively and non-covalently with a low-density lipoprotein receptor.
3 Q9JI18 (/IDA) Q9JI18 (/IDA) Q9JI18 (/IDA)
Coreceptor activity involved in Wnt signaling pathway GO:0071936
In cooperation with a primary Wnt receptor, initiating a change in cell activity through the Wnt signaling pathway.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Coreceptor activity involved in Wnt signaling pathway GO:0071936
In cooperation with a primary Wnt receptor, initiating a change in cell activity through the Wnt signaling pathway.
3 O75197 (/IPI) O75197 (/IPI) O75197 (/IPI)
Scaffold protein binding GO:0097110
Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
3 Q9QYP1 (/IPI) Q9QYP1 (/IPI) Q9QYP1 (/IPI)
Glycoprotein binding GO:0001948
Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans.
2 P35951 (/ISO) P98156 (/ISO)
Transmembrane signaling receptor activity GO:0004888
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
2 Q14114 (/TAS) Q92673 (/TAS)
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
2 A1Z9D7 (/ISS) A1Z9D7 (/ISS)
Epidermal growth factor receptor binding GO:0005154
Interacting selectively and non-covalently with the epidermal growth factor receptor.
2 P01132 (/IDA) P07522 (/IDA)
Epidermal growth factor receptor binding GO:0005154
Interacting selectively and non-covalently with the epidermal growth factor receptor.
2 P01133 (/TAS) P07522 (/TAS)
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
2 P10493 (/IDA) P14543 (/IDA)
Low-density lipoprotein particle binding GO:0030169
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
2 O88307 (/ISO) P35951 (/ISO)
Very-low-density lipoprotein particle receptor activity GO:0030229
Combining with a very-low-density lipoprotein particle and delivering the very-low-density lipoprotein into the cell via endocytosis.
2 P98156 (/ISS) P98166 (/ISS)
Reelin receptor activity GO:0038025
Combining with the secreted glycoprotein reelin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
2 P98156 (/IMP) Q924X6 (/IMP)
Reelin receptor activity GO:0038025
Combining with the secreted glycoprotein reelin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
2 P98155 (/ISS) Q14114 (/ISS)
Calcium-dependent protein binding GO:0048306
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules), in the presence of calcium.
2 P98155 (/IPI) Q924X6 (/IPI)
Beta-amyloid binding GO:0001540
Interacting selectively and non-covalently with beta-amyloid peptide/protein and/or its precursor.
1 Q92673 (/IDA)
Beta-amyloid binding GO:0001540
Interacting selectively and non-covalently with beta-amyloid peptide/protein and/or its precursor.
1 Q92673 (/IPI)
Beta-amyloid binding GO:0001540
Interacting selectively and non-covalently with beta-amyloid peptide/protein and/or its precursor.
1 O88307 (/ISO)
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
1 P35951 (/ISO)
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
1 P01133 (/EXP)
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
1 P01132 (/ISO)
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
1 P01133 (/TAS)
Receptor activity GO:0004872
Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
1 Q6X0I2 (/IDA)
Low-density lipoprotein receptor activity GO:0005041
Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
1 P01130 (/IC)
Ras guanyl-nucleotide exchange factor activity GO:0005088
Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
1 P01133 (/TAS)
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
1 P10493 (/ISO)
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
1 Q14112 (/TAS)
High-density lipoprotein particle binding GO:0008035
Interacting selectively and non-covalently with high-density lipoprotein particle, a lipoprotein particle with a high density (typically 1.063-1.21 g/ml) and a diameter of 5-10 nm that contains APOAs and may contain APOCs and APOE.
1 D3ZE75 (/IDA)
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
1 P01133 (/IDA)
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
1 P01132 (/ISO)
Vitellogenin receptor activity GO:0008196
Receiving vitellogenin, and delivering vitellogenin into the cell via endocytosis.
1 P98163 (/ISS)
Kinesin binding GO:0019894
Interacting selectively and non-covalently and stoichiometrically with kinesin, a member of a superfamily of microtubule-based motor proteins that perform force-generating tasks such as organelle transport and chromosome segregation.
1 D3ZE75 (/IPI)
Low-density lipoprotein particle binding GO:0030169
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
1 P35951 (/IDA)
Low-density lipoprotein particle binding GO:0030169
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
1 P01130 (/IMP)
Low-density lipoprotein particle binding GO:0030169
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
1 Q92673 (/IPI)
Lipoprotein particle receptor activity GO:0030228
Combining with a lipoprotein particle and delivering the lipoprotein particle into the cell via endocytosis. A lipoprotein particle, also known as a lipoprotein, is a clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids.
1 P98165 (/IC)
Protein tyrosine kinase activator activity GO:0030296
Increases the activity of a protein tyrosine kinase, an enzyme which phosphorylates a tyrosyl phenolic group on a protein.
1 P98166 (/TAS)
Transmembrane receptor protein tyrosine kinase activator activity GO:0030297
Binds to and increases the activity of a transmembrane receptor protein tyrosine kinase.
1 P01133 (/TAS)
ADP-ribosylation factor binding GO:0030306
Interacting selectively and non-covalently with ARF, ADP-ribosylation factor, a small monomeric cytosolic GTPase that, when bound to GTP, binds to the membranes of cells.
1 Q92673 (/IPI)
ADP-ribosylation factor binding GO:0030306
Interacting selectively and non-covalently with ARF, ADP-ribosylation factor, a small monomeric cytosolic GTPase that, when bound to GTP, binds to the membranes of cells.
1 O88307 (/ISO)
Clathrin heavy chain binding GO:0032050
Interacting selectively and non-covalently with a clathrin heavy chain.
1 P01130 (/TAS)
Apolipoprotein binding GO:0034185
Interacting selectively and non-covalently with an apolipoprotein, the protein component of a lipoprotein complex.
1 Q14114 (/IC)
Apolipoprotein binding GO:0034185
Interacting selectively and non-covalently with an apolipoprotein, the protein component of a lipoprotein complex.
1 P98155 (/ISS)
Very-low-density lipoprotein particle binding GO:0034189
Interacting selectively and non-covalently with a very-low-density lipoprotein particle, a triglyceride-rich lipoprotein particle that is typically composed of APOB100, APOE and APOCs and has a density of about 1.006 g/ml and a diameter of between 20-80 nm.
1 P98155 (/IDA)
Very-low-density lipoprotein particle binding GO:0034189
Interacting selectively and non-covalently with a very-low-density lipoprotein particle, a triglyceride-rich lipoprotein particle that is typically composed of APOB100, APOE and APOCs and has a density of about 1.006 g/ml and a diameter of between 20-80 nm.
1 P98156 (/ISO)
Glycoprotein transporter activity GO:0034437
Enables the directed movement of a glycoprotein, any protein that contains covalently bound glycose (i.e. monosaccharide) residues, into, out of or within a cell, or between cells.
1 P98155 (/IDA)
Glycoprotein transporter activity GO:0034437
Enables the directed movement of a glycoprotein, any protein that contains covalently bound glycose (i.e. monosaccharide) residues, into, out of or within a cell, or between cells.
1 P98156 (/ISO)
Reelin receptor activity GO:0038025
Combining with the secreted glycoprotein reelin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
1 P98156 (/IGI)
Laminin binding GO:0043236
Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
1 P14543 (/IDA)
Laminin binding GO:0043236
Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
1 P10493 (/ISO)
Laminin-1 binding GO:0043237
Interacting selectively and non-covalently with laminin-1, a glycoprotein trimer with the subunit composition alpha1, beta1, gamma1.
1 P10493 (/IDA)
Proteoglycan binding GO:0043394
Interacting selectively and non-covalently with a proteoglycan, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
1 P14543 (/IPI)
Proteoglycan binding GO:0043394
Interacting selectively and non-covalently with a proteoglycan, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
1 P10493 (/ISO)
Phosphatidylinositol-4,5-bisphosphate 3-kinase activity GO:0046934
Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
1 P01133 (/TAS)
Calcium-dependent protein binding GO:0048306
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules), in the presence of calcium.
1 P98156 (/ISO)
Extracellular matrix binding GO:0050840
Interacting selectively and non-covalently with a component of the extracellular matrix.
1 P10493 (/IDA)

There are 538 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
59 A0A0B4KHW9 (/IMP) A0A0B4KI25 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IVD8 (/IMP) A0A0R4IVD8 (/IMP)
(49 more)
Renal absorption GO:0070293
A renal system process in which water, ions, glucose and proteins are taken up from the collecting ducts, glomerulus and proximal and distal loops of the nephron. In non-mammalian species, absorption may occur in related structures (e.g. protein absorption is observed in nephrocytes in Drosophila, see PMID:23264686).
30 A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IAG0 (/IMP) A0A0R4IVD8 (/IMP) A0A0R4IVD8 (/IMP) A0A0R4IVD8 (/IMP) A0A0R4IVD8 (/IMP)
(20 more)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
20 A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) A1Z9D7 (/IMP) A1Z9D7 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP) O75197 (/IMP) O75197 (/IMP)
(10 more)
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
15 P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
(5 more)
Retinoid metabolic process GO:0001523
The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.
12 P35951 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
(2 more)
Lipid metabolic process GO:0006629
The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
12 P01130 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
(2 more)
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
12 P98155 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) Q6X0I2 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA)
(2 more)
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
12 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) O75581 (/IDA) O75581 (/IDA) O75581 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA) Q91VN0 (/IDA)
(2 more)
Positive regulation of lipid transport GO:0032370
Any process that activates or increases the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
12 A0A0B4KGZ9 (/IMP) A0A0B4KH38 (/IMP) A8JRC4 (/IMP) A8JRC7 (/IMP) Q7YTZ6 (/IMP) Q7YU01 (/IMP) Q86B77 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
(2 more)
Dendrite morphogenesis GO:0048813
The process in which the anatomical structures of a dendrite are generated and organized. A dendrite is a freely branching protoplasmic process of a nerve cell.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Negative regulation of axonogenesis GO:0050771
Any process that stops, prevents, or reduces the frequency, rate or extent of axonogenesis.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Synapse organization GO:0050808
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Synaptic growth at neuromuscular junction GO:0051124
The growth of a synapse at a neuromuscular junction, the site of apposition of a motor end plate and the subneural cleft of the skeletal muscle fiber that it innervates.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Protein heterotetramerization GO:0051290
The formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Skeletal muscle acetylcholine-gated channel clustering GO:0071340
The accumulation of acetylcholine-gated cation channels in a narrow, central region of muscle fibers, in apposition to nerve terminals.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Postsynaptic membrane assembly GO:0097104
The aggregation, arrangement and bonding together of a set of components to form a postsynaptic membrane, a specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft).
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Presynaptic membrane assembly GO:0097105
The aggregation, arrangement and bonding together of a set of components to form a presynaptic membrane, including any proteins associated with the membrane, but excluding other cellular components. A presynaptic membrane is a specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Positive regulation of presynaptic membrane organization GO:1901631
Any process that activates or increases the frequency, rate or extent of presynaptic membrane organization.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
11 G3V928 (/IEP) G3V928 (/IEP) G3V928 (/IEP) G3V928 (/IEP) P35952 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP)
(1 more)
Regulation of vasculature development GO:1901342
Any process that modulates the frequency, rate or extent of vasculature development.
11 A0A0H2UKL4 (/IMP) A0A0H2UKL4 (/IMP) A0A0H2UKL4 (/IMP) A0A0H2UKL4 (/IMP) A0A140LH31 (/IMP) A0A140LH43 (/IMP) F1QY34 (/IMP) F1QY34 (/IMP) F1QY34 (/IMP) F1QY34 (/IMP)
(1 more)
Cell proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
10 A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
10 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) O88572 (/IDA) O88572 (/IDA) O88572 (/IDA) P01133 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA)
Coronary vasculature development GO:0060976
The process whose specific outcome is the progression of the blood vessels of the heart over time, from its formation to the mature structure.
10 A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
9 A0A0B4KHW9 (/IEP) A0A0B4KI25 (/IEP) A8JRD0 (/IEP) A8JRD1 (/IEP) A8JRD2 (/IEP) E1JIX9 (/IEP) Q6NP71 (/IEP) Q9VBN0 (/IEP) Q9VBN1 (/IEP)
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
9 O75197 (/IGI) O75197 (/IGI) O75197 (/IGI) O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Forebrain development GO:0030900
The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
9 A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
9 A0A0G2K0H3 (/IEP) A0A0G2K0H3 (/IEP) A0A0G2K0H3 (/IEP) D3ZUH9 (/IEP) D3ZUH9 (/IEP) D3ZUH9 (/IEP) F1MAD0 (/IEP) F1MAD0 (/IEP) F1MAD0 (/IEP)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
9 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) O75581 (/IDA) O75581 (/IDA) O75581 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA)
Cholesterol metabolic process GO:0008203
The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues.
8 P35951 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
8 D3ZE75 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98166 (/IEP)
Neuron projection morphogenesis GO:0048812
The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites.
8 A0A0B4KGZ9 (/IMP) A0A0B4KH38 (/IMP) A8JRC4 (/IMP) A8JRC7 (/IMP) Q7YTZ6 (/IMP) Q7YU01 (/IMP) Q86B77 (/IMP) Q9VBN2 (/IMP)
Membrane organization GO:0061024
A process which results in the assembly, arrangement of constituent parts, or disassembly of a membrane. A membrane is a double layer of lipid molecules that encloses all cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins.
8 P01130 (/TAS) P01133 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS)
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
7 P01130 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS)
Chemical synaptic transmission GO:0007268
The vesicular release of classical neurotransmitter molecules from a neuron, across a chemical synapse, the subsequent activation of neurotransmitter receptors of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
7 A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP) Q924X6 (/IMP)
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
7 Q8VI56 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA)
Transcytosis GO:0045056
The directed movement of endocytosed material through the cell and its exocytosis from the plasma membrane at the opposite side.
7 P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) Q28832 (/IMP)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
7 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) P01132 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Gastrulation with mouth forming second GO:0001702
A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
6 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Positive regulation of mesenchymal cell proliferation GO:0002053
The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
6 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP) O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Ventricular septum development GO:0003281
The progression of the ventricular septum over time from its formation to the mature structure.
6 A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
6 A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP)
Vitamin metabolic process GO:0006766
The chemical reactions and pathways involving vitamins. Vitamin is a general term for a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. Vitamins may be water-soluble or fat-soluble and usually serve as components of coenzyme systems.
6 A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP)
Vitamin metabolic process GO:0006766
The chemical reactions and pathways involving vitamins. Vitamin is a general term for a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. Vitamins may be water-soluble or fat-soluble and usually serve as components of coenzyme systems.
6 P98158 (/TAS) P98158 (/TAS) P98158 (/TAS) P98158 (/TAS) P98158 (/TAS) P98158 (/TAS)
Positive regulation of cytosolic calcium ion concentration GO:0007204
Any process that increases the concentration of calcium ions in the cytosol.
6 A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
6 A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP)
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
6 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Response to X-ray GO:0010165
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers (corresponding to frequencies in the range 30 PHz to 3 EHz).
6 P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
Negative regulation of endopeptidase activity GO:0010951
Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
6 P98158 (/IC) P98158 (/IC) P98158 (/IC) P98158 (/IC) P98158 (/IC) P98158 (/IC)
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Endosomal transport GO:0016197
The directed movement of substances into, out of, or mediated by an endosome, a membrane-bounded organelle that carries materials newly ingested by endocytosis. It passes many of the materials to lysosomes for degradation.
6 P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP)
Single organismal cell-cell adhesion GO:0016337
The attachment of one cell to another cell via adhesion molecules, where both cells are part of the same organism.
6 A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) A0A0G2K0H3 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP) D3ZUH9 (/IMP)
Hemoglobin import GO:0020028
The directed movement into a tissue, cell or organelle of externally available hemoglobin.
6 P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP)
Cerebral cortex development GO:0021987
The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
6 D3ZE75 (/IEP) G3V928 (/IEP) G3V928 (/IEP) G3V928 (/IEP) G3V928 (/IEP) P98166 (/IEP)
Regulation of endocytosis GO:0030100
Any process that modulates the frequency, rate or extent of endocytosis.
6 A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP)
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
6 P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP)
Response to retinoic acid GO:0032526
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
6 P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP)
Response to vitamin D GO:0033280
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.
6 P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP) P98158 (/IEP)
Limb morphogenesis GO:0035108
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
6 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Aorta development GO:0035904
The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body.
6 A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP) A2ARV4 (/IMP)
Chitin-based cuticle development GO:0040003
Synthesis and deposition of a chitin-based noncellular, hardened, or membranous secretion from an epithelial sheet. An example of this process is found in Drosophila melanogaster.
6 A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP)
Cell migration involved in gastrulation GO:0042074
The migration of individual cells within the blastocyst to help establish the multi-layered body plan of the organism (gastrulation). For example, the migration of cells from the surface to the interior of the embryo (ingression).
6 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Vitamin D metabolic process GO:0042359
The chemical reactions and pathways involving vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).
6 P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS)
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
6 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Embryonic digit morphogenesis GO:0042733
The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
6 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Embryonic digit morphogenesis GO:0042733
The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
6 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Lipoprotein transport GO:0042953
The directed movement of any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
6 P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP)
Wnt signaling pathway involved in dorsal/ventral axis specification GO:0044332
The series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell contributing to the establishment, maintenance and elaboration of the dorsal/ventral axis.
6 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Wnt signaling pathway involved in dorsal/ventral axis specification GO:0044332
The series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell contributing to the establishment, maintenance and elaboration of the dorsal/ventral axis.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
6 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Bone remodeling GO:0046849
The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
6 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Hormone secretion GO:0046879
The regulated release of hormones, substances with a specific regulatory effect on a particular organ or group of cells.
6 P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP) P98158 (/IMP)
Regulation of adult chitin-containing cuticle pigmentation GO:0048082
Any process that modulates the frequency, rate or extent of establishment of the adult pattern of pigmentation in the cuticle of an organism.
6 A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP) A8JTM7 (/IMP)
Positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
6 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA)
Retina morphogenesis in camera-type eye GO:0060042
The process in which the anatomical structure of the retina is generated and organized.
6 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP) O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Branching involved in mammary gland duct morphogenesis GO:0060444
The process in which the branching structure of the mammary gland duct is generated and organized. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
6 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Mammary gland duct morphogenesis GO:0060603
The process in which anatomical structures of the mammary ducts are generated and organized. Mammary ducts are epithelial tubes that transport milk.
6 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Regulation of canonical Wnt signaling pathway GO:0060828
Any process that modulates the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
6 O75197 (/IGI) O75197 (/IGI) O75197 (/IGI) O75581 (/IGI) O75581 (/IGI) O75581 (/IGI)
Regulation of canonical Wnt signaling pathway GO:0060828
Any process that modulates the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
6 F1QTJ4 (/IMP) F1QTJ4 (/IMP) F1QTJ4 (/IMP) O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Regulation of canonical Wnt signaling pathway GO:0060828
Any process that modulates the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Negative regulation of protein serine/threonine kinase activity GO:0071901
Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity.
6 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
6 O75096 (/IDA) O75096 (/IDA) O75096 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA)
Beta-catenin destruction complex disassembly GO:1904886
The disaggregation of a beta-catenin destruction complex into its constituent components.
6 O75197 (/TAS) O75197 (/TAS) O75197 (/TAS) O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
STAT protein import into nucleus GO:0007262
The directed movement of dimerized STAT (Signal Transducers and Activators of Transcription) proteins into the nucleus following activation by members of the janus activated kinase (JAK) family of tyrosine kinases.
5 P01133 (/ISS) P07522 (/ISS) Q00968 (/ISS) Q95ND4 (/ISS) Q9BEA0 (/ISS)
Positive regulation of cell proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
5 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) P01132 (/IDA) P01133 (/IDA)
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
5 A1Z9D7 (/IMP) A1Z9D7 (/IMP) O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Regulation of cell migration GO:0030334
Any process that modulates the frequency, rate or extent of cell migration.
5 O01768 (/IGI) O01768 (/IGI) Q04833 (/IGI) Q04833 (/IGI) Q04833 (/IGI)
Cholesterol homeostasis GO:0042632
Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
5 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP) P01130 (/IMP) P35951 (/IMP)
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
5 P01133 (/ISS) P07522 (/ISS) Q00968 (/ISS) Q95ND4 (/ISS) Q9BEA0 (/ISS)
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
5 A0A0R4J0I9 (/IDA) A0A0R4J0I9 (/IDA) A0A0R4J0I9 (/IDA) A0A0R4J0I9 (/IDA) Q92673 (/IDA)
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
5 O88307 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Dendrite morphogenesis GO:0048813
The process in which the anatomical structures of a dendrite are generated and organized. A dendrite is a freely branching protoplasmic process of a nerve cell.
5 P98156 (/IMP) Q924X6 (/IMP) Q9QYP1 (/IMP) Q9QYP1 (/IMP) Q9QYP1 (/IMP)
Receptor-mediated endocytosis involved in cholesterol transport GO:0090118
A receptor-mediated endocytosis process involved in intracellular cholesterol transport.
5 E9QGD4 (/IMP) O88572 (/IMP) O88572 (/IMP) O88572 (/IMP) P01130 (/IMP)
Astrocyte activation involved in immune response GO:0002265
A change in the morphology or behavior of an astrocyte resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
4 A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI)
Astrocyte activation involved in immune response GO:0002265
A change in the morphology or behavior of an astrocyte resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Cardiac septum development GO:0003279
The progression of a cardiac septum over time, from its initial formation to the mature structure.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
4 A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI)
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Protein kinase C-activating G-protein coupled receptor signaling pathway GO:0007205
The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of protein kinase C (PKC). PKC is activated by second messengers including diacylglycerol (DAG).
4 G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP)
Positive regulation of cell proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
4 P01132 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Regulation of extracellular matrix disassembly GO:0010715
Any process that modulates the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Positive regulation of cholesterol efflux GO:0010875
Any process that increases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Positive regulation of cholesterol efflux GO:0010875
Any process that increases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
4 G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP)
Negative regulation of smooth muscle cell migration GO:0014912
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Negative regulation of smooth muscle cell migration GO:0014912
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Protein transport GO:0015031
The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
4 Q9NZR2 (/TAS) Q9NZR2 (/TAS) Q9NZR2 (/TAS) Q9NZR2 (/TAS)
Ventral spinal cord development GO:0021517
The process whose specific outcome is the progression of the ventral region of the spinal cord over time, from its formation to the mature structure. The neurons of the ventral region of the mature spinal cord participate in motor output.
4 P98156 (/IEP) P98165 (/IEP) Q924X6 (/IEP) Q98931 (/IEP)
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
4 O88322 (/TAS) P10493 (/TAS) P14543 (/TAS) Q14112 (/TAS)
Receptor internalization GO:0031623
A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Positive regulation of lipid transport GO:0032370
Any process that activates or increases the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Regulation of cholesterol transport GO:0032374
Any process that modulates the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Regulation of cholesterol transport GO:0032374
Any process that modulates the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Regulation of phospholipase A2 activity GO:0032429
Any process that modulates the activity of the enzyme phospholipase A2.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Regulation of phospholipase A2 activity GO:0032429
Any process that modulates the activity of the enzyme phospholipase A2.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Regulation of actin cytoskeleton organization GO:0032956
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Regulation of actin cytoskeleton organization GO:0032956
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Aorta morphogenesis GO:0035909
The process in which the anatomical structures of an aorta are generated and organized. An aorta is an artery that carries blood from the heart to other parts of the body.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Aorta morphogenesis GO:0035909
The process in which the anatomical structures of an aorta are generated and organized. An aorta is an artery that carries blood from the heart to other parts of the body.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Lipoprotein metabolic process GO:0042157
The chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
4 G3V928 (/IEP) G3V928 (/IEP) G3V928 (/IEP) G3V928 (/IEP)
Cholesterol homeostasis GO:0042632
Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
4 P35951 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Lipoprotein transport GO:0042953
The directed movement of any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
4 Q07954 (/NAS) Q07954 (/NAS) Q07954 (/NAS) Q07954 (/NAS)
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
4 G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP)
Transcytosis GO:0045056
The directed movement of endocytosed material through the cell and its exocytosis from the plasma membrane at the opposite side.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
4 Q07954 (/IMP) Q07954 (/IMP) Q07954 (/IMP) Q07954 (/IMP)
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
4 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) P01133 (/IDA)
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
4 P01132 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
4 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP) Q924X6 (/IMP)
Positive regulation of protein transport GO:0051222
Any process that activates or increases the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
4 G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP) G3V928 (/IMP)
Regulation of protein metabolic process GO:0051246
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein.
4 A0A0R4J0I9 (/IMP) A0A0R4J0I9 (/IMP) A0A0R4J0I9 (/IMP) A0A0R4J0I9 (/IMP)
Regulation of protein metabolic process GO:0051246
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Beta-amyloid clearance GO:0097242
The process in which beta-amyloid is removed from the brain via receptors.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Beta-amyloid clearance GO:0097242
The process in which beta-amyloid is removed from the brain via receptors.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Cellular response to beta-amyloid GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a beta-amyloid stimulus.
4 A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI) A0A0R4J0I9 (/IGI)
Cellular response to beta-amyloid GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a beta-amyloid stimulus.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Positive regulation of lysosomal protein catabolic process GO:1905167
Any process that activates or increases the frequency, rate or extent of lysosomal protein catabolic process.
4 Q07954 (/IMP) Q07954 (/IMP) Q07954 (/IMP) Q07954 (/IMP)
Negative regulation of platelet-derived growth factor receptor-beta signaling pathway GO:2000587
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
4 Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP) Q91ZX7 (/IMP)
Negative regulation of platelet-derived growth factor receptor-beta signaling pathway GO:2000587
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
3 Q9JI18 (/IMP) Q9JI18 (/IMP) Q9JI18 (/IMP)
Neural crest cell migration GO:0001755
The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
3 F1QTJ4 (/IMP) F1QTJ4 (/IMP) F1QTJ4 (/IMP)
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
3 O75096 (/IDA) O75096 (/IDA) O75096 (/IDA)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
3 Q8VI56 (/ISO) Q8VI56 (/ISO) Q8VI56 (/ISO)
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Liver development GO:0001889
The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
3 F1QTJ4 (/IGI) F1QTJ4 (/IGI) F1QTJ4 (/IGI)
Liver development GO:0001889
The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
3 F1QTJ4 (/IMP) F1QTJ4 (/IMP) F1QTJ4 (/IMP)
Regulation of protein phosphorylation GO:0001932
Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
3 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Positive regulation of mesenchymal cell proliferation GO:0002053
The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Osteoblast development GO:0002076
The process whose specific outcome is the progression of an osteoblast over time, from its formation to the mature structure. Osteoblast development does not include the steps involved in committing a cranial neural crest cell or an osteoprogenitor cell to an osteoblast fate. An osteoblast is a cell that gives rise to bone.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Nematode larval development GO:0002119
The process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.
3 Q04833 (/IMP) Q04833 (/IMP) Q04833 (/IMP)
Pericardium morphogenesis GO:0003344
The process in which the anatomical structure of the pericardium is generated and organized.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Axis elongation GO:0003401
The developmental growth that results in the elongation of a line that defines polarity or symmetry in an anatomical structure.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Glucose catabolic process GO:0006007
The chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Glucose catabolic process GO:0006007
The chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Negative regulation of protein kinase activity GO:0006469
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity.
3 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Negative regulation of protein kinase activity GO:0006469
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
3 P01133 (/TAS) P98155 (/TAS) Q14114 (/TAS)
Blood circulation GO:0008015
The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products.
3 A0A140LGI0 (/IMP) F1QGQ2 (/IMP) F1QKU8 (/IMP)
Protein localization GO:0008104
Any process in which a protein is transported to, or maintained in, a specific location.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Regulation of blood pressure GO:0008217
Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Regulation of blood pressure GO:0008217
Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Response to radiation GO:0009314
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
3 F1MAD0 (/IEP) F1MAD0 (/IEP) F1MAD0 (/IEP)
Embryonic pattern specification GO:0009880
The process that results in the patterns of cell differentiation that will arise in an embryo.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Dorsal/ventral axis specification GO:0009950
The establishment, maintenance and elaboration of the dorsal/ventral axis. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Proximal/distal pattern formation GO:0009954
The regionalization process in which specific areas of cell differentiation are determined along a proximal/distal axis. The proximal/distal axis is defined by a line that runs from main body (proximal end) of an organism outward (distal end).
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Neural crest formation GO:0014029
The formation of the specialized region of ectoderm between the neural ectoderm (neural plate) and non-neural ectoderm. The neural crest gives rise to the neural crest cells that migrate away from this region as neural tube formation procedes.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Neural crest formation GO:0014029
The formation of the specialized region of ectoderm between the neural ectoderm (neural plate) and non-neural ectoderm. The neural crest gives rise to the neural crest cells that migrate away from this region as neural tube formation procedes.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Neural crest cell differentiation GO:0014033
The process in which a relatively unspecialized cell acquires specialized features of a neural crest cell.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Neural crest cell differentiation GO:0014033
The process in which a relatively unspecialized cell acquires specialized features of a neural crest cell.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Sterol transport GO:0015918
The directed movement of sterols into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Sterols are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.
3 Q04833 (/IMP) Q04833 (/IMP) Q04833 (/IMP)
Cerebellum morphogenesis GO:0021587
The process in which the anatomical structure of the cerebellum is generated and organized. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. The cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Thalamus development GO:0021794
The process in which the thalamus changes over time, from its initial formation to its mature state.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Cerebral cortex cell migration GO:0021795
The orderly movement of cells from one site to another in the cerebral cortex.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Forebrain radial glial cell differentiation GO:0021861
The process in which neuroepithelial cells of the neural tube give rise to radial glial cells, specialized bipotential progenitors cells of the forebrain. Differentiation includes the processes involved in commitment of a cell to a specific fate.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Forebrain generation of neurons GO:0021872
The process in which nerve cells are generated in the forebrain. This includes the production of neuroblasts from and their differentiation into neurons.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Wnt signaling pathway involved in forebrain neuroblast division GO:0021874
The series of molecular signals initiated by binding of Wnt protein to a receptor on the surface of the target cell that contributes to the self renewal of neuroblasts in the forebrain.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Wnt signaling pathway involved in forebrain neuroblast division GO:0021874
The series of molecular signals initiated by binding of Wnt protein to a receptor on the surface of the target cell that contributes to the self renewal of neuroblasts in the forebrain.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Formation of radial glial scaffolds GO:0021943
The formation of scaffolds from a radial glial cell. The scaffolds are used as a substrate for the radial migration of cells.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Cerebral cortex development GO:0021987
The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of ossification GO:0030279
Any process that stops, prevents, or reduces the frequency, rate or extent of bone formation.
3 O75096 (/IMP) O75096 (/IMP) O75096 (/IMP)
Negative regulation of ossification GO:0030279
Any process that stops, prevents, or reduces the frequency, rate or extent of bone formation.
3 Q8VI56 (/ISO) Q8VI56 (/ISO) Q8VI56 (/ISO)
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Midbrain development GO:0030901
The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Midbrain-hindbrain boundary development GO:0030917
The process whose specific outcome is the progression of the midbrain-hindbrain boundary over time, from its formation to the mature structure. The midbrain-hindbrain domain of the embryonic brain is comprised of the mesencephalic vesicle and the first rhombencephalic vesicle at early somitogenesis stages.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Positive regulation of osteoblast proliferation GO:0033690
Any process that activates or increases the rate or extent of osteoblast proliferation.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Negative regulation of smooth muscle cell apoptotic process GO:0034392
Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.
3 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Negative regulation of smooth muscle cell apoptotic process GO:0034392
Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Limb morphogenesis GO:0035108
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Embryonic forelimb morphogenesis GO:0035115
The process, occurring in the embryo, by which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an animal, e.g. the arms of a human.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Embryonic forelimb morphogenesis GO:0035115
The process, occurring in the embryo, by which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an animal, e.g. the arms of a human.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Embryonic hindlimb morphogenesis GO:0035116
The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Embryonic hindlimb morphogenesis GO:0035116
The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
External genitalia morphogenesis GO:0035261
The process in which the anatomical structures of the external genitalia are generated and organized. The external genitalia are the outer sex organs, such as the penis or vulva in mammals.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Extracellular matrix-cell signaling GO:0035426
Any process that mediates the transfer of information between the extracellular matrix and a cell.
3 Q91VN0 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA)
Post-anal tail morphogenesis GO:0036342
The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Post-anal tail morphogenesis GO:0036342
The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Positive regulation of locomotion GO:0040017
Any process that activates or increases the frequency, rate or extent of locomotion of a cell or organism.
3 Q04833 (/IMP) Q04833 (/IMP) Q04833 (/IMP)
Positive regulation of multicellular organism growth GO:0040018
Any process that activates or increases the frequency, rate or extent of growth of an organism to reach its usual body size.
3 Q04833 (/IMP) Q04833 (/IMP) Q04833 (/IMP)
Regulation of cell proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Ecdysis, collagen and cuticulin-based cuticle GO:0042395
The shedding of the old collagen and cuticulin-based cuticle fragments during the molting cycle. Examples of this process are found in invertebrates.
3 Q04833 (/IMP) Q04833 (/IMP) Q04833 (/IMP)
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Receptor clustering GO:0043113
The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Canonical Wnt signaling pathway involved in neural crest cell differentiation GO:0044335
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in neural crest cell differentiation.
3 O75581 (/IC) O75581 (/IC) O75581 (/IC)
Canonical Wnt signaling pathway involved in regulation of cell proliferation GO:0044340
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contributes to modulating the rate or frequency of cell proliferation.
3 O75581 (/IC) O75581 (/IC) O75581 (/IC)
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Positive regulation of fat cell differentiation GO:0045600
Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Positive regulation of fat cell differentiation GO:0045600
Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Negative regulation of osteoblast differentiation GO:0045668
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Negative regulation of osteoblast differentiation GO:0045668
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of bone formation.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Positive regulation of bone resorption GO:0045780
Any process that activates or increases the frequency, rate or extent of bone resorption.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Positive regulation of cell cycle GO:0045787
Any process that activates or increases the rate or extent of progression through the cell cycle.
3 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Positive regulation of cell cycle GO:0045787
Any process that activates or increases the rate or extent of progression through the cell cycle.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
3 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Bone remodeling GO:0046849
The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Regulation of bone remodeling GO:0046850
Any process that modulates the frequency, rate or extent of bone remodeling, the processes of bone formation and resorption that combine to maintain skeletal integrity.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Bone marrow development GO:0048539
The process whose specific outcome is the progression of the bone marrow over time, from its formation to the mature structure.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Bone marrow development GO:0048539
The process whose specific outcome is the progression of the bone marrow over time, from its formation to the mature structure.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Embryonic camera-type eye morphogenesis GO:0048596
The process in which the anatomical structures of the eye are generated and organized during embryonic development.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Generation of neurons GO:0048699
The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Embryonic viscerocranium morphogenesis GO:0048703
The process in which the anatomical structures of the viscerocranium are generated and organized during the embryonic phase. The viscerocranium is the part of the skull comprising the facial bones.
3 F1QTJ4 (/IMP) F1QTJ4 (/IMP) F1QTJ4 (/IMP)
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Anatomical structure development GO:0048856
The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Negative regulation of axonogenesis GO:0050771
Any process that stops, prevents, or reduces the frequency, rate or extent of axonogenesis.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Synapse organization GO:0050808
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
3 Q9QYP1 (/IMP) Q9QYP1 (/IMP) Q9QYP1 (/IMP)
Positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Synaptic growth at neuromuscular junction GO:0051124
The growth of a synapse at a neuromuscular junction, the site of apposition of a motor end plate and the subneural cleft of the skeletal muscle fiber that it innervates.
3 Q8VI56 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA)
Synaptic growth at neuromuscular junction GO:0051124
The growth of a synapse at a neuromuscular junction, the site of apposition of a motor end plate and the subneural cleft of the skeletal muscle fiber that it innervates.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
3 A0A140LGI0 (/IMP) F1QGQ2 (/IMP) F1QKU8 (/IMP)
Protein heterotetramerization GO:0051290
The formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical.
3 Q9QYP1 (/IDA) Q9QYP1 (/IDA) Q9QYP1 (/IDA)
Response to folic acid GO:0051593
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Palate development GO:0060021
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Convergent extension GO:0060026
The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Anatomical structure regression GO:0060033
The developmental process in which an anatomical stucture is destroyed as a part of its normal progression.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Retina morphogenesis in camera-type eye GO:0060042
The process in which the anatomical structure of the retina is generated and organized.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Embryonic retina morphogenesis in camera-type eye GO:0060059
The process in which the anatomical structure of the retina is generated and organized in a camera-type eye during the embryonic life stage.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
3 O88572 (/ISS) O88572 (/ISS) O88572 (/ISS)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
3 O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
Limb development GO:0060173
The process whose specific outcome is the progression of a limb over time, from its formation to the mature structure. A limb is an appendage of an animal used for locomotion or grasping. Examples include legs, arms or some types of fin.
3 O75096 (/IDA) O75096 (/IDA) O75096 (/IDA)
Limb development GO:0060173
The process whose specific outcome is the progression of a limb over time, from its formation to the mature structure. A limb is an appendage of an animal used for locomotion or grasping. Examples include legs, arms or some types of fin.
3 Q8VI56 (/ISO) Q8VI56 (/ISO) Q8VI56 (/ISO)
Regulation of cell development GO:0060284
Any process that modulates the rate, frequency or extent of the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Bone morphogenesis GO:0060349
The process in which bones are generated and organized.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Bone morphogenesis GO:0060349
The process in which bones are generated and organized.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Trachea cartilage morphogenesis GO:0060535
The process in which the anatomical structures of cartilage in the trachea are generated and organized.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Mammary placode formation GO:0060596
The developmental process in which the mammary placode forms. The mammary placode is a transient lens shaped structure that will give rise to the mammary bud proper.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Adipose tissue development GO:0060612
The process whose specific outcome is the progression of adipose tissue over time, from its formation to the mature structure. Adipose tissue is specialized tissue that is used to store fat.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Adipose tissue development GO:0060612
The process whose specific outcome is the progression of adipose tissue over time, from its formation to the mature structure. Adipose tissue is specialized tissue that is used to store fat.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Cell-cell signaling involved in mammary gland development GO:0060764
Any process that mediates the transfer of information from one cell to another and contributes to the progression of the mammary gland, from its initial state to the mature structure.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Regulation of insulin secretion involved in cellular response to glucose stimulus GO:0061178
Any process that modulates the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Retina vasculature morphogenesis in camera-type eye GO:0061299
The process in which the vasculature of the retina is generated and organized.
3 Q91VN0 (/IGI) Q91VN0 (/IGI) Q91VN0 (/IGI)
Retina vasculature morphogenesis in camera-type eye GO:0061299
The process in which the vasculature of the retina is generated and organized.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Retinal blood vessel morphogenesis GO:0061304
The process whose specific outcome is the progression of a blood vessel of the retina over time, from its formation to the mature structure.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Retinal blood vessel morphogenesis GO:0061304
The process whose specific outcome is the progression of a blood vessel of the retina over time, from its formation to the mature structure.
3 Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development GO:0061310
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in cardiac neural crest cell differentiation.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation GO:0061324
The canonical Wnt signaling pathway that contributes to the modulation of the expansion of a population of cardiac outflow tract cells.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Skeletal muscle acetylcholine-gated channel clustering GO:0071340
The accumulation of acetylcholine-gated cation channels in a narrow, central region of muscle fibers, in apposition to nerve terminals.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Cellular response to cholesterol GO:0071397
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
3 O75581 (/IMP) O75581 (/IMP) O75581 (/IMP)
Cellular response to cholesterol GO:0071397
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
3 O75581 (/ISS) O75581 (/ISS) O75581 (/ISS)
Negative regulation of protein serine/threonine kinase activity GO:0071901
Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Negative regulation of protein serine/threonine kinase activity GO:0071901
Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity.
3 O75197 (/IMP) O75197 (/IMP) O75197 (/IMP)
Protein localization to plasma membrane GO:0072659
A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
3 O75581 (/IPI) O75581 (/IPI) O75581 (/IPI)
Protein localization to plasma membrane GO:0072659
A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Primitive streak formation GO:0090009
The developmental process pertaining to the initial formation of the primitive streak from unspecified parts. The primitive streak is a ridge of cells running along the midline of the embryo where the mesoderm ingresses. It defines the anterior-posterior axis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
3 Q8VI56 (/IGI) Q8VI56 (/IGI) Q8VI56 (/IGI)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
3 O75096 (/IMP) O75096 (/IMP) O75096 (/IMP)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
3 Q8VI56 (/ISO) Q8VI56 (/ISO) Q8VI56 (/ISO)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
3 O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
Wnt signaling pathway involved in somitogenesis GO:0090244
The series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state that contributes to somitogenesis.
3 O88572 (/IMP) O88572 (/IMP) O88572 (/IMP)
Axis elongation involved in somitogenesis GO:0090245
The developmental growth that results in the elongation of the rostral-caudal axis that contributes to somitogenesis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Postsynaptic membrane assembly GO:0097104
The aggregation, arrangement and bonding together of a set of components to form a postsynaptic membrane, a specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft).
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Presynaptic membrane assembly GO:0097105
The aggregation, arrangement and bonding together of a set of components to form a presynaptic membrane, including any proteins associated with the membrane, but excluding other cellular components. A presynaptic membrane is a specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Positive regulation of presynaptic membrane organization GO:1901631
Any process that activates or increases the frequency, rate or extent of presynaptic membrane organization.
3 Q8VI56 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA)
Apoptotic process involved in blood vessel morphogenesis GO:1902262
Any apoptotic process that is involved in blood vessel morphogenesis.
3 Q91VN0 (/IMP) Q91VN0 (/IMP) Q91VN0 (/IMP)
Positive regulation of skeletal muscle acetylcholine-gated channel clustering GO:1904395
Any process that activates or increases the frequency, rate or extent of skeletal muscle acetylcholine-gated channel clustering.
3 Q8VI56 (/IMP) Q8VI56 (/IMP) Q8VI56 (/IMP)
Midbrain dopaminergic neuron differentiation GO:1904948
The process in which a relatively unspecialized cell acquires the specialized features of a midbrain dopaminergic neuron.
3 O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation GO:1904953
Any Wnt signaling pathway that is involved in midbrain dopaminergic neuron differentiation.
3 O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
Negative regulation of non-canonical Wnt signaling pathway GO:2000051
Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification GO:2000055
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification GO:2000055
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis GO:2000149
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis GO:2000151
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis GO:2000162
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis GO:2000164
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of planar cell polarity pathway involved in pericardium morphogenesis GO:2000166
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of planar cell polarity pathway involved in neural tube closure GO:2000168
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Negative regulation of transcription from RNA polymerase II promoter GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2 P98156 (/IMP) Q924X6 (/IMP)
Negative regulation of transcription from RNA polymerase II promoter GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2 P98155 (/ISS) Q14114 (/ISS)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
2 P35952 (/IEP) P98166 (/IEP)
Compound eye morphogenesis GO:0001745
The morphogenetic process in which the anatomical structures of the compound eye are generated and organized. The adult compound eye is a precise assembly of 700-800 ommatidia. Each ommatidium is composed of 20 cells, identified by cell type and position. An example of compound eye morphogenesis is found in Drosophila melanogaster.
2 A1Z9D7 (/IMP) A1Z9D7 (/IMP)
Protein targeting GO:0006605
The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif.
2 O88307 (/ISS) Q95209 (/ISS)
Protein targeting to lysosome GO:0006622
The process of directing proteins towards the lysosome using signals contained within the protein.
2 A1Z9D7 (/IMP) A1Z9D7 (/IMP)
Cell-matrix adhesion GO:0007160
The binding of a cell to the extracellular matrix via adhesion molecules.
2 O88322 (/IDA) P10493 (/IDA)
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
2 P01132 (/IDA) P07522 (/IDA)
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
2 P01132 (/TAS) P01133 (/TAS)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
2 A1Z9D7 (/IMP) A1Z9D7 (/IMP)
Long-term memory GO:0007616
The memory process that deals with the storage, retrieval and modification of information a long time (typically weeks, months or years) after receiving that information. This type of memory is typically dependent on gene transcription regulated by second messenger activation.
2 A1Z9D7 (/IMP) A1Z9D7 (/IMP)
Response to hormone GO:0009725
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
2 P35952 (/IEP) P98166 (/IEP)
Regulation of smooth muscle cell migration GO:0014910
Any process that modulates the frequency, rate or extent of smooth muscle cell migration.
2 Q92673 (/IDA) Q95209 (/IDA)
Extracellular matrix disassembly GO:0022617
A process that results in the breakdown of the extracellular matrix.
2 P10493 (/TAS) P14543 (/TAS)
Cholesterol transport GO:0030301
The directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
2 P01130 (/IMP) P35951 (/IMP)
Low-density lipoprotein particle clearance GO:0034383
The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
2 P01130 (/IMP) P35951 (/IMP)
Very-low-density lipoprotein particle clearance GO:0034447
The process in which a very-low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
2 P98156 (/ISS) P98166 (/ISS)
Reelin-mediated signaling pathway GO:0038026
A series of molecular signals initiated by the binding of reelin (a secreted glycoprotein) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
2 P98155 (/ISS) Q14114 (/ISS)
Positive regulation of protein kinase activity GO:0045860
Any process that activates or increases the frequency, rate or extent of protein kinase activity.
2 P98156 (/IGI) Q924X6 (/IGI)
Regulation of compound eye pigmentation GO:0048076
Any process that modulates the frequency, rate or extent of establishment of a pattern of pigment in the compound eye.
2 A1Z9D7 (/IMP) A1Z9D7 (/IMP)
Cholesterol import GO:0070508
The directed movement of cholesterol into a cell or organelle.
2 P01130 (/IMP) P35951 (/IMP)
Basement membrane organization GO:0071711
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane.
2 P14543 (/TAS) Q14112 (/TAS)
Positive regulation of dendrite development GO:1900006
Any process that activates or increases the frequency, rate or extent of dendrite development.
2 P98156 (/IGI) Q924X6 (/IGI)
Positive regulation of dendrite development GO:1900006
Any process that activates or increases the frequency, rate or extent of dendrite development.
2 P98155 (/ISS) Q14114 (/ISS)
Negative regulation of beta-amyloid formation GO:1902430
Any process that stops, prevents or reduces the frequency, rate or extent of beta-amyloid formation.
2 O88307 (/IMP) Q92673 (/IMP)
Negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process GO:1902960
Any process that stops, prevents or reduces the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process.
2 O88307 (/IMP) Q92673 (/IMP)
Negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process GO:1902963
Any process that stops, prevents or reduces the frequency, rate or extent of metalloendopeptidase activity involved in amyloid precursor protein catabolic process.
2 O88307 (/IMP) Q92673 (/IMP)
Protein targeting to Golgi GO:0000042
The process of directing proteins towards the Golgi; usually uses signals contained within the protein.
1 Q92673 (/IDA)
Protein targeting to Golgi GO:0000042
The process of directing proteins towards the Golgi; usually uses signals contained within the protein.
1 O88307 (/ISO)
Protein targeting to Golgi GO:0000042
The process of directing proteins towards the Golgi; usually uses signals contained within the protein.
1 O88307 (/ISS)
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
1 P01133 (/TAS)
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
1 P01132 (/IDA)
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
1 P01132 (/IDA)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
1 P01133 (/IDA)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
1 P01132 (/ISO)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
1 P07522 (/IEP)
Positive regulation of receptor internalization GO:0002092
Any process that activates or increases the frequency, rate or extent of receptor internalization.
1 P01133 (/IDA)
Positive regulation of receptor internalization GO:0002092
Any process that activates or increases the frequency, rate or extent of receptor internalization.
1 P01132 (/ISO)
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
1 P01133 (/TAS)
DNA replication GO:0006260
The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA.
1 P01133 (/TAS)
Proteolysis GO:0006508
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
1 Q14114 (/NAS)
Protein targeting GO:0006605
The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif.
1 Q92673 (/IDA)
Protein targeting GO:0006605
The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif.
1 Q92673 (/IMP)
Protein targeting GO:0006605
The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif.
1 O88307 (/ISO)
Protein targeting to lysosome GO:0006622
The process of directing proteins towards the lysosome using signals contained within the protein.
1 Q92673 (/IDA)
Protein targeting to lysosome GO:0006622
The process of directing proteins towards the lysosome using signals contained within the protein.
1 O88307 (/ISO)
Protein targeting to lysosome GO:0006622
The process of directing proteins towards the lysosome using signals contained within the protein.
1 O88307 (/ISS)
Lipid metabolic process GO:0006629
The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
1 P35951 (/IGI)
Lipid metabolic process GO:0006629
The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
1 Q14114 (/NAS)
Post-Golgi vesicle-mediated transport GO:0006892
The directed movement of substances from the Golgi to other parts of the cell, including organelles and the plasma membrane, mediated by small transport vesicles.
1 Q92673 (/IDA)
Post-Golgi vesicle-mediated transport GO:0006892
The directed movement of substances from the Golgi to other parts of the cell, including organelles and the plasma membrane, mediated by small transport vesicles.
1 O88307 (/ISO)
Post-Golgi vesicle-mediated transport GO:0006892
The directed movement of substances from the Golgi to other parts of the cell, including organelles and the plasma membrane, mediated by small transport vesicles.
1 O88307 (/ISS)
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
1 Q14114 (/IDA)
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
1 P35952 (/IMP)
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
1 Q924X6 (/ISO)
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
1 Q924X6 (/ISS)
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
1 P98156 (/ISO)
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
1 Q14112 (/TAS)
Cell-matrix adhesion GO:0007160
The binding of a cell to the extracellular matrix via adhesion molecules.
1 O88322 (/IPI)
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
1 P98166 (/TAS)
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
1 P01132 (/IGI)
STAT protein import into nucleus GO:0007262
The directed movement of dimerized STAT (Signal Transducers and Activators of Transcription) proteins into the nucleus following activation by members of the janus activated kinase (JAK) family of tyrosine kinases.
1 P01132 (/IDA)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
1 P98155 (/TAS)
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
1 P98155 (/TAS)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
1 P98166 (/IEP)
Response to nutrient GO:0007584
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
1 P98166 (/IEP)
Memory GO:0007613
The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).
1 P98155 (/TAS)
Positive regulation of cell proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
1 P01132 (/IGI)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 P35951 (/IGI)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 P35951 (/IMP)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 P35951 (/IMP)
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
1 P01133 (/IDA)
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
1 P01132 (/ISO)
Positive regulation of cell-substrate adhesion GO:0010811
Any process that increases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
1 P10493 (/IDA)
Positive regulation of triglyceride biosynthetic process GO:0010867
Any process that increases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.
1 P35951 (/IMP)
Positive regulation of triglyceride biosynthetic process GO:0010867
Any process that increases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.
1 P01130 (/ISS)
Regulation of phosphatidylcholine catabolic process GO:0010899
Any process that modulates the rate, frequency or extent of phosphatidylcholine catabolism. Phosphatidylcholine catabolic processes are the chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
1 P35951 (/IMP)
Regulation of phosphatidylcholine catabolic process GO:0010899
Any process that modulates the rate, frequency or extent of phosphatidylcholine catabolism. Phosphatidylcholine catabolic processes are the chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
1 P01130 (/ISS)
Regulation of phosphatidylinositol 3-kinase signaling GO:0014066
Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
1 P01133 (/TAS)
Regulation of smooth muscle cell migration GO:0014910
Any process that modulates the frequency, rate or extent of smooth muscle cell migration.
1 O88307 (/ISO)
Phospholipid transport GO:0015914
The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are any lipids containing phosphoric acid as a mono- or diester.
1 P35951 (/IMP)
Phospholipid transport GO:0015914
The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are any lipids containing phosphoric acid as a mono- or diester.
1 P01130 (/ISS)
Peptidyl-tyrosine phosphorylation GO:0018108
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
1 P01132 (/IDA)
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 Q14114 (/NAS)
Ammon gyrus development GO:0021541
The process whose specific outcome is the progression of the ammon gyrus over time, from its formation to the mature structure. The ammon gyrus, often subdivided into the CA1 and CA3 regions, is one of the two interlocking gyri of the hippocampus that is rich in large pyramidal neurons.
1 Q924X6 (/IMP)
Ammon gyrus development GO:0021541
The process whose specific outcome is the progression of the ammon gyrus over time, from its formation to the mature structure. The ammon gyrus, often subdivided into the CA1 and CA3 regions, is one of the two interlocking gyri of the hippocampus that is rich in large pyramidal neurons.
1 Q14114 (/ISS)
Hippocampus development GO:0021766
The progression of the hippocampus over time from its initial formation until its mature state.
1 Q924X6 (/IGI)
Layer formation in cerebral cortex GO:0021819
The detachment of cells from radial glial fibers at the appropriate time when they cease to migrate and form distinct layer in the cerebral cortex.
1 Q924X6 (/IGI)
Positive regulation of cerebellar granule cell precursor proliferation GO:0021940
The process that activates or increases the rate or extent of granule cell precursor proliferation.
1 P01132 (/IDA)
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
1 P10493 (/IDA)
Intestinal cholesterol absorption GO:0030299
Uptake of cholesterol into the blood by absorption from the small intestine.
1 P01130 (/IMP)
Intestinal cholesterol absorption GO:0030299
Uptake of cholesterol into the blood by absorption from the small intestine.
1 P35951 (/ISO)
Cholesterol transport GO:0030301
The directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
1 P35951 (/ISO)
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
1 Q92673 (/IDA)
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
1 O88307 (/ISO)
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
1 O88307 (/ISS)
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
1 P35952 (/IEP)
Negative regulation of protein oligomerization GO:0032460
Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization.
1 Q92673 (/IMP)
Negative regulation of protein oligomerization GO:0032460
Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization.
1 O88307 (/ISO)
Negative regulation of protein oligomerization GO:0032460
Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization.
1 O88307 (/ISS)
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
1 P98166 (/IEP)
Positive regulation of CREB transcription factor activity GO:0032793
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.
1 Q924X6 (/IMP)
Positive regulation of CREB transcription factor activity GO:0032793
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.
1 Q14114 (/ISS)
Low-density lipoprotein particle receptor catabolic process GO:0032802
The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
1 P98155 (/TAS)
Glomerular basement membrane development GO:0032836
The process whose specific outcome is the progression of the glomerular basement membrane over time, from its formation to the mature structure. The glomerular basement membrane is the basal laminal portion of the glomerulus which performs the actual filtration.
1 P10493 (/IMP)
Cellular response to insulin stimulus GO:0032869
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
1 P98166 (/IEP)
Response to glucagon GO:0033762
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
1 P35952 (/IEP)
Chylomicron remnant clearance GO:0034382
The process in which a chylomicron remnant is removed from the blood via receptor-mediated endocytosis into liver cells and its constituent parts degraded.
1 P01130 (/TAS)
Low-density lipoprotein particle clearance GO:0034383
The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
1 P35951 (/IDA)
Low-density lipoprotein particle clearance GO:0034383
The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
1 P35951 (/ISO)
Low-density lipoprotein particle clearance GO:0034383
The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
1 P01130 (/TAS)
Glycoprotein transport GO:0034436
The directed movement of a glycoprotein, any protein that contains covalently bound glycose (i.e. monosaccharide) residues, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
1 P98155 (/IDA)
Glycoprotein transport GO:0034436
The directed movement of a glycoprotein, any protein that contains covalently bound glycose (i.e. monosaccharide) residues, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
1 P98156 (/ISO)
Very-low-density lipoprotein particle clearance GO:0034447
The process in which a very-low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
1 P98155 (/IDA)
Very-low-density lipoprotein particle clearance GO:0034447
The process in which a very-low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
1 P98156 (/ISO)
Very-low-density lipoprotein particle clearance GO:0034447
The process in which a very-low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
1 P98155 (/TAS)
Positive regulation of catenin import into nucleus GO:0035413
Any process that increases the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus.
1 P01133 (/IDA)
Positive regulation of catenin import into nucleus GO:0035413
Any process that increases the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus.
1 P01132 (/ISO)
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
1 P07522 (/TAS)
Reelin-mediated signaling pathway GO:0038026
A series of molecular signals initiated by the binding of reelin (a secreted glycoprotein) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 P98156 (/IGI)
Reelin-mediated signaling pathway GO:0038026
A series of molecular signals initiated by the binding of reelin (a secreted glycoprotein) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 Q924X6 (/IMP)
ERBB2 signaling pathway GO:0038128
A series of molecular signals initiated by binding of a ligand to a member of the ERBB family of receptors on the surface of a cell, where the signal is transmitted by ERBB2. The pathway ends with regulation of a downstream cellular process, e.g. transcription. ERBB2 receptors are themselves unable to bind to ligands, but act as a signal-amplifying tyrosine kinase within a heterodimeric pair.
1 P01133 (/TAS)
Negative regulation of epidermal growth factor receptor signaling pathway GO:0042059
Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
1 P01133 (/TAS)
Cellular response to glucose starvation GO:0042149
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of glucose.
1 P98166 (/IEP)
Lipoprotein metabolic process GO:0042157
The chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
1 P35951 (/IGI)
Lipoprotein catabolic process GO:0042159
The chemical reactions and pathways resulting in the breakdown of any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
1 P35951 (/IDA)
Lipoprotein catabolic process GO:0042159
The chemical reactions and pathways resulting in the breakdown of any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
1 P35951 (/IMP)
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
1 P01133 (/IDA)
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
1 P01132 (/ISO)
Cholesterol homeostasis GO:0042632
Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
1 P35951 (/IGI)
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
1 P01132 (/IDA)
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
1 P01133 (/IDA)
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
1 P01132 (/ISO)
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
1 O88307 (/IMP)
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
1 Q92673 (/ISS)
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
1 P35952 (/IEP)
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
1 Q92673 (/TAS)
Protein retention in Golgi apparatus GO:0045053
The retention of proteins within the Golgi apparatus. Golgi-localized carbohydrate-modifying enzymes have a short N-terminal domain that faces the cytosol, a single transmembrane alpha helix, and a large C-terminal domain that faces the Golgi lumen and that contains the catalytic site. How the membrane-spanning alpha helix in a Golgi enzyme causes its localization and prevents its movement to the plasma membrane is not known.
1 Q92673 (/IDA)
Protein retention in Golgi apparatus GO:0045053
The retention of proteins within the Golgi apparatus. Golgi-localized carbohydrate-modifying enzymes have a short N-terminal domain that faces the cytosol, a single transmembrane alpha helix, and a large C-terminal domain that faces the Golgi lumen and that contains the catalytic site. How the membrane-spanning alpha helix in a Golgi enzyme causes its localization and prevents its movement to the plasma membrane is not known.
1 O88307 (/IMP)
Protein retention in Golgi apparatus GO:0045053
The retention of proteins within the Golgi apparatus. Golgi-localized carbohydrate-modifying enzymes have a short N-terminal domain that faces the cytosol, a single transmembrane alpha helix, and a large C-terminal domain that faces the Golgi lumen and that contains the catalytic site. How the membrane-spanning alpha helix in a Golgi enzyme causes its localization and prevents its movement to the plasma membrane is not known.
1 O88307 (/ISO)
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
1 O88307 (/ISO)
Positive regulation of epidermal growth factor-activated receptor activity GO:0045741
Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity.
1 P01133 (/IDA)
Positive regulation of epidermal growth factor-activated receptor activity GO:0045741
Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity.
1 P01133 (/IMP)
Positive regulation of epidermal growth factor-activated receptor activity GO:0045741
Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity.
1 P01132 (/ISO)
Positive regulation of epidermal growth factor-activated receptor activity GO:0045741
Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity.
1 P01133 (/TAS)
Phosphatidylinositol-mediated signaling GO:0048015
A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
1 P01133 (/TAS)
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
1 P07522 (/IDA)
Oogenesis GO:0048477
The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
1 P98163 (/NAS)
Oogenesis GO:0048477
The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
1 P98163 (/TAS)
Branching morphogenesis of an epithelial tube GO:0048754
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
1 P01132 (/IDA)
Regulation of protein secretion GO:0050708
Any process that modulates the frequency, rate or extent of the controlled release of a protein from a cell.
1 P07522 (/IMP)
Positive regulation of inflammatory response GO:0050729
Any process that activates or increases the frequency, rate or extent of the inflammatory response.
1 P35951 (/IGI)
Regulation of peptidyl-tyrosine phosphorylation GO:0050730
Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
1 P01132 (/IDA)
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
1 P01132 (/IDA)
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
1 Q14114 (/ISS)
Negative regulation of neurogenesis GO:0050768
Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the origin and formation of neurons.
1 O88307 (/IMP)
Negative regulation of neurogenesis GO:0050768
Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the origin and formation of neurons.
1 Q92673 (/ISS)
Modulation of synaptic transmission GO:0050804
Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission.
1 Q924X6 (/IMP)
Modulation of synaptic transmission GO:0050804
Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission.
1 Q14114 (/ISS)
Negative regulation of secretion GO:0051048
Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a substance from a cell or a tissue.
1 P01133 (/IDA)
Negative regulation of secretion GO:0051048
Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a substance from a cell or a tissue.
1 P01132 (/ISO)
Regulation of protein transport GO:0051223
Any process that modulates the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
1 P07522 (/IDA)
Regulation of protein transport GO:0051223
Any process that modulates the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
1 P01132 (/ISO)
Protein maturation GO:0051604
Any process leading to the attainment of the full functional capacity of a protein.
1 Q92673 (/IDA)
Protein maturation GO:0051604
Any process leading to the attainment of the full functional capacity of a protein.
1 O88307 (/ISO)
Protein maturation GO:0051604
Any process leading to the attainment of the full functional capacity of a protein.
1 O88307 (/ISS)
Mammary gland alveolus development GO:0060749
The progression of the mammary gland alveolus over time, from its formation to its mature state. The mammary gland alveolus is a sac-like structure that is found in the mature gland.
1 P01132 (/IGI)
Positive regulation of dendritic spine morphogenesis GO:0061003
Any process that increases the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
1 Q924X6 (/IMP)
Positive regulation of dendritic spine morphogenesis GO:0061003
Any process that increases the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
1 Q14114 (/ISS)
Positive regulation of protein tyrosine kinase activity GO:0061098
Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
1 P01132 (/IDA)
Positive regulation of protein tyrosine kinase activity GO:0061098
Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
1 Q924X6 (/IMP)
Positive regulation of protein tyrosine kinase activity GO:0061098
Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
1 Q14114 (/ISS)
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
1 P01133 (/IDA)
ERK1 and ERK2 cascade GO:0070371
An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
1 P01132 (/ISO)
Cholesterol import GO:0070508
The directed movement of cholesterol into a cell or organelle.
1 P35951 (/ISO)
Cholesterol import GO:0070508
The directed movement of cholesterol into a cell or organelle.
1 P01130 (/ISS)
Positive regulation of protein exit from endoplasmic reticulum GO:0070863
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the endoplasmic reticulum.
1 Q92673 (/IMP)
Positive regulation of protein exit from endoplasmic reticulum GO:0070863
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the endoplasmic reticulum.
1 O88307 (/ISO)
Positive regulation of protein exit from endoplasmic reticulum GO:0070863
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the endoplasmic reticulum.
1 O88307 (/ISS)
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
1 P98166 (/IEP)
Cellular response to interleukin-1 GO:0071347
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
1 P98166 (/IEP)
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
1 D3ZE75 (/IEP)
Cellular response to cholesterol GO:0071397
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
1 D3ZE75 (/IEP)
Cellular response to fatty acid GO:0071398
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.
1 P35951 (/IGI)
Cellular response to low-density lipoprotein particle stimulus GO:0071404
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
1 P01130 (/IMP)
Cellular response to low-density lipoprotein particle stimulus GO:0071404
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
1 P35951 (/ISO)
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 P98166 (/IDA)
Receptor-mediated endocytosis involved in cholesterol transport GO:0090118
A receptor-mediated endocytosis process involved in intracellular cholesterol transport.
1 P35951 (/ISO)
Regulation of calcium ion import GO:0090279
Any process that modulates the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.
1 P01133 (/IDA)
Regulation of calcium ion import GO:0090279
Any process that modulates the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.
1 P01132 (/ISO)
Negative regulation of cholesterol efflux GO:0090370
Any process that decreases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
1 P01132 (/IDA)
Positive regulation of hyaluronan biosynthetic process GO:1900127
Any process that activates or increases the frequency, rate or extent of hyaluronan biosynthetic process.
1 P01133 (/IDA)
Positive regulation of hyaluronan biosynthetic process GO:1900127
Any process that activates or increases the frequency, rate or extent of hyaluronan biosynthetic process.
1 P01132 (/ISO)
Negative regulation of ERBB signaling pathway GO:1901185
Any process that stops, prevents or reduces the frequency, rate or extent of ERBB signaling pathway.
1 P01133 (/TAS)
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
1 O88307 (/IMP)
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
1 Q92673 (/ISS)
Negative regulation of beta-amyloid formation GO:1902430
Any process that stops, prevents or reduces the frequency, rate or extent of beta-amyloid formation.
1 Q92673 (/IDA)
Negative regulation of beta-amyloid formation GO:1902430
Any process that stops, prevents or reduces the frequency, rate or extent of beta-amyloid formation.
1 O88307 (/ISO)
Positive regulation of choline O-acetyltransferase activity GO:1902771
Any process that activates or increases the frequency, rate or extent of choline O-acetyltransferase activity.
1 O88307 (/IMP)
Positive regulation of choline O-acetyltransferase activity GO:1902771
Any process that activates or increases the frequency, rate or extent of choline O-acetyltransferase activity.
1 Q92673 (/ISS)
Negative regulation of tau-protein kinase activity GO:1902948
Any process that stops, prevents or reduces the frequency, rate or extent of tau-protein kinase activity.
1 O88307 (/IMP)
Negative regulation of tau-protein kinase activity GO:1902948
Any process that stops, prevents or reduces the frequency, rate or extent of tau-protein kinase activity.
1 Q92673 (/ISS)
Positive regulation of ER to Golgi vesicle-mediated transport GO:1902953
Any process that activates or increases the frequency, rate or extent of ER to Golgi vesicle-mediated transport.
1 Q92673 (/IMP)
Positive regulation of ER to Golgi vesicle-mediated transport GO:1902953
Any process that activates or increases the frequency, rate or extent of ER to Golgi vesicle-mediated transport.
1 O88307 (/ISO)
Positive regulation of ER to Golgi vesicle-mediated transport GO:1902953
Any process that activates or increases the frequency, rate or extent of ER to Golgi vesicle-mediated transport.
1 O88307 (/ISS)
Positive regulation of early endosome to recycling endosome transport GO:1902955
Any process that activates or increases the frequency, rate or extent of early endosome to recycling endosome transport.
1 Q92673 (/IMP)
Positive regulation of early endosome to recycling endosome transport GO:1902955
Any process that activates or increases the frequency, rate or extent of early endosome to recycling endosome transport.
1 O88307 (/ISO)
Positive regulation of early endosome to recycling endosome transport GO:1902955
Any process that activates or increases the frequency, rate or extent of early endosome to recycling endosome transport.
1 O88307 (/ISS)
Negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process GO:1902960
Any process that stops, prevents or reduces the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process.
1 Q92673 (/IDA)
Negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process GO:1902960
Any process that stops, prevents or reduces the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process.
1 O88307 (/ISO)
Negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process GO:1902963
Any process that stops, prevents or reduces the frequency, rate or extent of metalloendopeptidase activity involved in amyloid precursor protein catabolic process.
1 O88307 (/ISO)
Positive regulation of protein localization to early endosome GO:1902966
Any process that activates or increases the frequency, rate or extent of protein localization to early endosome.
1 Q92673 (/IMP)
Positive regulation of protein localization to early endosome GO:1902966
Any process that activates or increases the frequency, rate or extent of protein localization to early endosome.
1 O88307 (/ISO)
Positive regulation of protein localization to early endosome GO:1902966
Any process that activates or increases the frequency, rate or extent of protein localization to early endosome.
1 O88307 (/ISS)
Negative regulation of neurofibrillary tangle assembly GO:1902997
Any process that stops, prevents or reduces the frequency, rate or extent of neurofibrillary tangle assembly.
1 O88307 (/IMP)
Negative regulation of neurofibrillary tangle assembly GO:1902997
Any process that stops, prevents or reduces the frequency, rate or extent of neurofibrillary tangle assembly.
1 Q92673 (/ISS)
Regulation of protein localization to cell surface GO:2000008
Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
1 P01133 (/IDA)
Regulation of protein localization to cell surface GO:2000008
Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
1 P01132 (/ISO)
Positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process GO:2000060
Any process that activates or increases the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.
1 P01132 (/IDA)
Regulation of cell motility GO:2000145
Any process that modulates the frequency, rate or extent of cell motility.
1 P01133 (/TAS)
Regulation of cholesterol homeostasis GO:2000188
Any process that modulates the frequency, rate or extent of cholesterol homeostasis.
1 P35951 (/IMP)
Positive regulation of DNA biosynthetic process GO:2000573
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
1 P07522 (/IDA)
Positive regulation of endocytic recycling GO:2001137
Any process that activates or increases the frequency, rate or extent of endocytic recycling.
1 Q92673 (/IMP)
Positive regulation of endocytic recycling GO:2001137
Any process that activates or increases the frequency, rate or extent of endocytic recycling.
1 O88307 (/ISO)
Positive regulation of endocytic recycling GO:2001137
Any process that activates or increases the frequency, rate or extent of endocytic recycling.
1 O88307 (/ISS)

There are 136 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
35 A0A0B4KGZ9 (/IDA) A0A0B4KH38 (/IDA) A1Z9D7 (/IDA) A1Z9D7 (/IDA) A8JRC4 (/IDA) A8JRC7 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA)
(25 more)
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
29 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) D3ZE75 (/IDA) O88572 (/IDA) O88572 (/IDA) O88572 (/IDA)
(19 more)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
26 O75197 (/TAS) O75197 (/TAS) O75197 (/TAS) O75581 (/TAS) O75581 (/TAS) O75581 (/TAS) P01130 (/TAS) P01132 (/TAS) P01133 (/TAS) P35951 (/TAS)
(16 more)
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
21 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA)
(11 more)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
20 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) P01130 (/ISS)
(10 more)
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
20 O75197 (/IDA) O75197 (/IDA) O75197 (/IDA) P01130 (/IDA) P98155 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA)
(10 more)
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
19 A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) P35951 (/ISO) P98156 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
(9 more)
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
18 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) G3V928 (/IDA) G3V928 (/IDA) G3V928 (/IDA) G3V928 (/IDA)
(8 more)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
16 O88322 (/IDA) P01132 (/IDA) P01133 (/IDA) P07522 (/IDA) P10493 (/IDA) P35951 (/IDA) P98156 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
(6 more)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
16 A0A0B4KFD1 (/IDA) A0A0B4KFD1 (/IDA) A0A0B4KFD1 (/IDA) A1Z7C4 (/IDA) A1Z7C4 (/IDA) A1Z7C4 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA) A8JTM7 (/IDA)
(6 more)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
14 B5DFC9 (/IDA) O75096 (/IDA) O75096 (/IDA) O75096 (/IDA) O75581 (/IDA) O75581 (/IDA) O75581 (/IDA) P01130 (/IDA) P01131 (/IDA) P35951 (/IDA)
(4 more)
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
14 A0A0G2K0H3 (/IDA) A0A0G2K0H3 (/IDA) A0A0G2K0H3 (/IDA) D3ZE75 (/IDA) D3ZUH9 (/IDA) D3ZUH9 (/IDA) D3ZUH9 (/IDA) G3V928 (/IDA) G3V928 (/IDA) G3V928 (/IDA)
(4 more)
Lysosomal membrane GO:0005765
The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
13 P01133 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA)
(3 more)
Brush border GO:0005903
The dense covering of microvilli on the apical surface of a epithelial cells in tissues such as the intestine, kidney, and choroid plexus; the microvilli aid absorption by increasing the surface area of the cell.
12 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
(2 more)
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane in asymetric synapses. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Dendrite GO:0030425
A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Brush border membrane GO:0031526
The portion of the plasma membrane surrounding the brush border.
12 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
(2 more)
Neuromuscular junction GO:0031594
The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q9QYP1 (/ISS)
(2 more)
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Synaptic membrane GO:0097060
A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.
12 H2Q3I3 (/ISS) H2Q3I3 (/ISS) H2Q3I3 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) H9FUD8 (/ISS) O75096 (/ISS) O75096 (/ISS) O75096 (/ISS) Q8VI56 (/ISS)
(2 more)
Lysosomal membrane GO:0005765
The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
11 A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) P01132 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
(1 more)
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
10 P01133 (/IDA) P14543 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) P98164 (/IDA) Q14112 (/IDA) Q92673 (/IDA)
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
10 A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) A2ARV4 (/ISO) O88307 (/ISO) O88322 (/ISO) P01132 (/ISO) P10493 (/ISO)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
9 O75581 (/TAS) O75581 (/TAS) O75581 (/TAS) O88322 (/TAS) P01132 (/TAS) P01133 (/TAS) P10493 (/TAS) P14543 (/TAS) Q14112 (/TAS)
Endocytic vesicle GO:0030139
A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.
9 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) Q04833 (/IDA) Q04833 (/IDA) Q04833 (/IDA)
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
8 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) P01130 (/IDA) Q92673 (/IDA)
Dendrite GO:0030425
A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
8 D3ZE75 (/IDA) G3V928 (/IDA) G3V928 (/IDA) G3V928 (/IDA) G3V928 (/IDA) Q9QYP1 (/IDA) Q9QYP1 (/IDA) Q9QYP1 (/IDA)
Apical part of cell GO:0045177
The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
8 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) P35951 (/IDA) P98166 (/IDA)
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
7 O88307 (/ISS) P01131 (/ISS) P20063 (/ISS) P35950 (/ISS) P35951 (/ISS) P35952 (/ISS) Q28832 (/ISS)
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
7 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) Q92673 (/IDA)
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
7 P01131 (/ISS) P20063 (/ISS) P35950 (/ISS) P35951 (/ISS) P35952 (/ISS) Q28832 (/ISS) Q95209 (/ISS)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
7 O88322 (/ISO) O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO) Q91VN0 (/ISO)
Clathrin-coated pit GO:0005905
A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
7 A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) A2ARV4 (/IDA) P01130 (/IDA)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
7 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO) P35951 (/ISO) Q8VI56 (/ISO) Q8VI56 (/ISO) Q8VI56 (/ISO)
Clathrin-coated vesicle membrane GO:0030665
The lipid bilayer surrounding a clathrin-coated vesicle.
7 P01133 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
6 P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
6 P01131 (/ISS) P20063 (/ISS) P35950 (/ISS) P35951 (/ISS) P35952 (/ISS) Q28832 (/ISS)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
6 P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS) P98164 (/TAS)
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
6 O88572 (/IDA) O88572 (/IDA) O88572 (/IDA) P01130 (/IDA) P35951 (/IDA) Q92673 (/IDA)
Late endosome GO:0005770
A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
6 P01131 (/ISS) P20063 (/ISS) P35950 (/ISS) P35951 (/ISS) P35952 (/ISS) Q28832 (/ISS)
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
6 P98164 (/ISS) P98164 (/ISS) P98164 (/ISS) P98164 (/ISS) P98164 (/ISS) P98164 (/ISS)
Protein complex GO:0043234
A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.
6 P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
6 P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA) P98158 (/IDA)
Synapse GO:0045202
The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
6 A0A0G2K0H3 (/IDA) A0A0G2K0H3 (/IDA) A0A0G2K0H3 (/IDA) D3ZUH9 (/IDA) D3ZUH9 (/IDA) D3ZUH9 (/IDA)
Wnt-Frizzled-LRP5/6 complex GO:1990851
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
6 O75197 (/TAS) O75197 (/TAS) O75197 (/TAS) O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
Wnt signalosome GO:1990909
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
6 O75197 (/NAS) O75197 (/NAS) O75197 (/NAS) O75581 (/NAS) O75581 (/NAS) O75581 (/NAS)
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
5 O88307 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
4 O88322 (/IDA) P10493 (/IDA) P14543 (/IDA) Q14112 (/IDA)
Nucleolus GO:0005730
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
4 Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA)
Nucleolus GO:0005730
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
4 Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
4 Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
4 Q91ZX7 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA) Q91ZX7 (/IDA)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
4 Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS) Q07954 (/ISS)
Focal adhesion GO:0005925
Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
4 Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA) Q07954 (/IDA)
Focal adhesion GO:0005925
Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
4 Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO) Q91ZX7 (/ISO)
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane in asymetric synapses. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
4 D3ZE75 (/IDA) Q9QYP1 (/IDA) Q9QYP1 (/IDA) Q9QYP1 (/IDA)
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
4 O88307 (/ISO) P35951 (/ISO) P98156 (/ISO) Q924X6 (/ISO)
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
4 Q07954 (/NAS) Q07954 (/NAS) Q07954 (/NAS) Q07954 (/NAS)
Clathrin-coated vesicle GO:0030136
A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes.
4 G3V928 (/IDA) G3V928 (/IDA) G3V928 (/IDA) G3V928 (/IDA)
Endocytic vesicle membrane GO:0030666
The lipid bilayer surrounding an endocytic vesicle.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
4 O88322 (/IDA) P10493 (/IDA) P14543 (/IDA) Q14112 (/IDA)
Cytoplasmic vesicle GO:0031410
A vesicle found in the cytoplasm of a cell.
4 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA) P98163 (/IDA)
Plasma membrane protein complex GO:0098797
Any protein complex that is part of the plasma membrane.
4 Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS) Q07954 (/TAS)
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
3 Q91VN0 (/IDA) Q91VN0 (/IDA) Q91VN0 (/IDA)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
3 O88572 (/IGI) O88572 (/IGI) O88572 (/IGI)
Caveola GO:0005901
A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
3 P01131 (/IDA) P35952 (/IDA) Q14114 (/IDA)
Cytoplasmic vesicle GO:0031410
A vesicle found in the cytoplasm of a cell.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Neuromuscular junction GO:0031594
The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential.
3 Q8VI56 (/IC) Q8VI56 (/IC) Q8VI56 (/IC)
Neuromuscular junction GO:0031594
The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential.
3 Q8VI56 (/IDA) Q8VI56 (/IDA) Q8VI56 (/IDA)
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
3 O75581 (/TAS) O75581 (/TAS) O75581 (/TAS)
Synaptic membrane GO:0097060
A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.
3 Q9QYP1 (/IDA) Q9QYP1 (/IDA) Q9QYP1 (/IDA)
Wnt-Frizzled-LRP5/6 complex GO:1990851
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Wnt-Frizzled-LRP5/6 complex GO:1990851
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
3 O75581 (/IPI) O75581 (/IPI) O75581 (/IPI)
Wnt-Frizzled-LRP5/6 complex GO:1990851
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Wnt signalosome GO:1990909
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
3 O75581 (/IDA) O75581 (/IDA) O75581 (/IDA)
Wnt signalosome GO:1990909
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
3 O88572 (/ISO) O88572 (/ISO) O88572 (/ISO)
Proteinaceous extracellular matrix GO:0005578
A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.
2 O88322 (/IDA) P10493 (/IDA)
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
2 O88322 (/IPI) P10493 (/IPI)
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
2 O88322 (/ISO) P10493 (/ISO)
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
2 P10493 (/TAS) Q14112 (/TAS)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
2 O88307 (/ISO) P01132 (/ISO)
Nuclear envelope lumen GO:0005641
The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide.
2 O88307 (/IDA) Q92673 (/IDA)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
2 P01130 (/IDA) P35951 (/IDA)
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
2 O88307 (/ISO) P35951 (/ISO)
Late endosome GO:0005770
A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
2 P01130 (/IDA) P35951 (/IDA)
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
2 O88307 (/ISO) P35951 (/ISO)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
2 P01130 (/TAS) Q92673 (/TAS)
Endosome membrane GO:0010008
The lipid bilayer surrounding an endosome.
2 P01130 (/TAS) Q92673 (/TAS)
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
2 O88322 (/ISO) P10493 (/ISO)
Golgi membrane GO:0000139
The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
1 Q92673 (/TAS)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
1 P01133 (/IC)
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
1 A1Z877 (/ISS)
Basal lamina GO:0005605
A thin sheet of proteoglycans and glycoproteins, especially laminin, secreted by cells as an extracellular matrix.
1 P10493 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 P98166 (/IDA)
Nuclear envelope lumen GO:0005641
The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide.
1 O88307 (/ISO)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
1 P35951 (/ISO)
Lysosomal membrane GO:0005765
The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
1 P98155 (/TAS)
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
1 O88307 (/ISO)
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
1 Q95209 (/ISS)
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
1 Q92673 (/IMP)
Late endosome GO:0005770
A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
1 P35951 (/ISO)
Multivesicular body GO:0005771
A type of endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm.
1 P01131 (/IDA)
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
1 O88307 (/ISO)
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
1 O88307 (/ISS)
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
1 Q92673 (/IDA)
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
1 O88307 (/ISO)
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
1 O88307 (/ISS)
Microtubule associated complex GO:0005875
Any multimeric complex connected to a microtubule.
1 D3ZE75 (/IDA)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
1 Q14114 (/NAS)
Caveola GO:0005901
A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
1 Q924X6 (/ISO)
Clathrin-coated pit GO:0005905
A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
1 P35951 (/ISO)
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
1 P01130 (/IDA)
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
1 P35951 (/ISO)
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
1 Q14114 (/IC)
Basolateral plasma membrane GO:0016323
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
1 P35951 (/IDA)
Basolateral plasma membrane GO:0016323
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
1 P01130 (/ISS)
Coated vesicle GO:0030135
Small membrane-bounded organelle formed by pinching off of a coated region of membrane. Some coats are made of clathrin, whereas others are made from other proteins.
1 P98163 (/IDA)
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
1 D3ZE75 (/IDA)
Clathrin-coated endocytic vesicle membrane GO:0030669
The lipid bilayer surrounding a clathrin-coated endocytic vesicle.
1 P01130 (/TAS)
Platelet alpha granule lumen GO:0031093
The volume enclosed by the membrane of the platelet alpha granule.
1 P01133 (/TAS)
Golgi cisterna GO:0031985
Any of the thin, flattened membrane-bounded compartments that form the central portion of the Golgi complex.
1 Q92673 (/IDA)
Golgi cisterna GO:0031985
Any of the thin, flattened membrane-bounded compartments that form the central portion of the Golgi complex.
1 O88307 (/ISO)
Golgi cisterna GO:0031985
Any of the thin, flattened membrane-bounded compartments that form the central portion of the Golgi complex.
1 O88307 (/ISS)
Endolysosome membrane GO:0036020
The lipid bilayer surrounding an endolysosome. An endolysosome is a transient hybrid organelle formed by fusion of a late endosome with a lysosome.
1 P01130 (/TAS)
Cell body GO:0044297
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
1 H0Z4W1 (/IDA)
Apical part of cell GO:0045177
The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
1 P01130 (/ISS)
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
1 P98166 (/IDA)
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
1 Q92673 (/IMP)
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
1 O88307 (/ISO)
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
1 O88307 (/ISS)
Recycling endosome membrane GO:0055038
The lipid bilayer surrounding a recycling endosome.
1 P35952 (/IDA)
Cell periphery GO:0071944
The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures.
1 P10493 (/IDA)
Sorting endosome GO:0097443
A multivesicular body surrounded by and connected with multiple tubular compartments with associated vesicles.
1 P35951 (/IDA)
PCSK9-LDLR complex GO:1990666
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
1 P01130 (/IDA)
PCSK9-LDLR complex GO:1990666
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
1 P35951 (/ISO)
PCSK9-LDLR complex GO:1990666
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
1 P35951 (/ISS)
CATH-Gene3D is a Global Biodata Core Resource Learn more...